- Home
- VKTX vs FBP Comparison
VKTX vs FBP Comparison
Compare VKTX & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | FBP |
|---|---|---|
| Founded | 2012 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 2014 | 2010 |
Fundamental Metrics
Financial Performance| Metric | VKTX | FBP |
|---|---|---|
| Price | $38.04 | $26.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $95.86 | $25.50 |
| AVG Volume (30 Days) | ★ 2.5M | 1.7M |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 18.78 |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $1,255,034,000.00 |
| Revenue This Year | N/A | $15.10 |
| Revenue Next Year | N/A | $4.65 |
| P/E Ratio | ★ N/A | $46.56 |
| Revenue Growth | N/A | ★ 2.38 |
| 52 Week Low | $22.96 | $19.16 |
| 52 Week High | $43.15 | $26.80 |
Technical Indicators
Market Signals| Indicator | VKTX | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 73.64 | 66.08 |
| Support Level | $33.65 | $23.30 |
| Resistance Level | $39.78 | N/A |
| Average True Range (ATR) | 1.92 | 0.48 |
| MACD | 1.07 | 0.12 |
| Stochastic Oscillator | 87.55 | 73.19 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Mortgage Banking; Consumer (Retail) Banking; Commercial and Corporate Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. The Consumer (Retail) Banking segment generates the majority of revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.